Skip to main content
Andras Heczey, MD, Pediatric Hematology & Oncology, Houston, TX

Andras Heczey MD


Associate professor, Pediatric Hematology & Oncology, Baylor College of Medicine

Join to View Full Profile
  • 1102 Bates AveHouston, TX 77030

  • Phone+1 832-824-1000

Dr. Heczey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Andras Heczey's research focuses on developing novel treatments for children with solid tumors by redirecting the immune system to attack and kill cancer cells by using genetically-engineered T cells and Natural Killer T cells. He developed bispecific T cell engagers and chimeric antigen receptors which specifically target several solid tumors (including hepatoblastoma, hepatocellular carcinoma, yolk sac tumors, Wilms tumor, rhabdoid tumors etc) when expressed in T cells.
    As the Director of the Liver Tumor Center, Dr. Heczey developed a strategy to target glypican-3 (GPC3) with genetically-engineered T lymphocytes. His team is currently evaluating Interleukin-15 and GPC3-CAR expressing T cells in children with solid tumors.
    His ultimate goal is to cure all patients with solid cancers by effectively translating preclinical findings from bench-to-bedside.

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
  • Children's Hospital Los Angeles
    Children's Hospital Los AngelesResidency, Pediatrics, 2006 - 2009
  • Semmelweis University
    Semmelweis UniversityClass of 2002

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2010 - 2026
  • CA State Medical License
    CA State Medical License 2009 - 2025
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • From Bench to Bedside and Back: CAR T Cells Armed with IL-15 Show Promise in Treating Solid Cancers
    From Bench to Bedside and Back: CAR T Cells Armed with IL-15 Show Promise in Treating Solid CancersJanuary 28th, 2025
  • CAR T Cells Armed with IL-15 Show Promise in Treating Solid Cancers
    CAR T Cells Armed with IL-15 Show Promise in Treating Solid CancersNovember 27th, 2024
  • Promising Results for CAR-NKT Cell Therapy Against Neuroblastoma in Phase 1 Trial
    Promising Results for CAR-NKT Cell Therapy Against Neuroblastoma in Phase 1 TrialMay 16th, 2023
  • Join now to see all

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: